ENV-101

· Endeavor Biomedicines, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ENV-101, covering 2024-12-02 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations [Phase 2]

See pricing